6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0023 770-24-4-801-0662 -National CMOP DORZOLAMIDE HCL 2% OPH SOLN
ID: 36C77025Q0023Type: Presolicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/97232707585d4965a88f62a95adfba23/view
Timeline
    Description

    The Department of Veterans Affairs (VA) is seeking qualified vendors to fulfill an emergency procurement of Dorzolamide HCL 2% Ophthalmic Solution, packaged in 10 mL bottles, under solicitation number 36C77025Q0023. The procurement involves delivering a total of over 18,000 units to multiple VA Consolidated Mail Outpatient Pharmacy (CMOP) locations across the United States, emphasizing compliance with the Drug Supply Chain Security Act and a preference for U.S.-made products. This ophthalmic solution is critical for supporting the healthcare needs of veterans, ensuring timely access to essential pharmaceuticals. Interested vendors must submit their quotes, including a signed SF1449 cover page, a price schedule in Excel format, and proof of state wholesale distributor licensure by October 16, 2024, at 09:00 AM CST, to the contact specialist, Michael McAlhaney, at Michael.McAlhaney@va.gov.

    Point(s) of Contact
    McAlhaney, Michael W.Contract Specialist
    (913) 684-0134
    Michael.McAlhaney@va.gov
    Files
    Title
    Posted
    36C77025Q0023_1.docx
    The document outlines a Request for Proposals (RFP) from the Department of Veterans Affairs, specifically targeting the procurement of pharmaceutical supplies. The solicitation, numbered 36C77025Q0023, emphasizes the need for compliance with federal regulations, including the Drug Supply Chain Security Act (DSCSA). Key requirements include submission of a price schedule, state distributor licenses, and adherence to specific packaging and labeling standards, such as barcoding for pharmaceuticals. Contractors must guarantee availability and confirm pricing shortly before order placement. Delivery terms are stringent, requiring products to be shipped via USPS where applicable and delivered to multiple specified locations. The solicitation incorporates clauses regarding payment methods and invoicing standards, emphasizing electronic submissions to streamline financial transactions. In addition, the document details administrative responsibilities for contract management, stipulating that any deviations from proposed terms must receive prior approval from the contracting officer. Overall, this procurement initiative aims to ensure the efficient delivery of pharmaceutical needs while maintaining compliance with regulatory and operational standards during the process.
    36C77025Q0023.docx
    The Department of Veterans Affairs (VA) National CMOP Contracting Office has issued a presolicitation notice for an emergency procurement of Dorzolamide HCL 2% ophthalmic solution, indicating urgent requirements for multiple locations. The solicitation number is 36C77025Q0023, with a response deadline set for October 16, 2024, at 09:00 AM Central Time. The required quantities vary by item, totaling over 18,000 units distributed across seven locations. The solicitation includes important stipulations such as compliance with the Drug Supply Chain Security Act and a preference for U.S.-made products. Vendors are required to submit a price schedule, state wholesale distributor licenses, and completed forms via email to the contact specialist, Michael McAlhaney. Proposals must adhere to specified formats, including an Excel price schedule, to avoid technical disqualification. The notice serves as a critical step in ensuring the timely availability of essential pharmaceuticals to support VA healthcare services.
    52.225-6 TRADE AGREEMENTS CERTIFICATE.docx
    The document outlines the requirements of the Trade Agreements Certificate (FAR 52.225-6) for federal government solicitations. It mandates that offerors must certify that each final product is a U.S.-made or qualifies as a designated country end product, unless specified otherwise. If any products do not meet these criteria, offerors must list them along with their country of origin. The evaluation of offers will align with the Federal Acquisition Regulation policies, particularly for items covered under the World Trade Organization Government Procurement Agreement (WTO GPA), where U.S. or designated country products are prioritized without Buy American restrictions. Offers of non-U.S.-made products will only be considered when the Contracting Officer finds insufficient U.S. or designated country bids. This document is crucial for ensuring compliance with trade agreements in government procurement processes.
    S02_Solicitation_Attachment_Pricing SpreadSheet_RFQ_36C77025Q0023.xlsx
    The document outlines a Request for Quote (RFQ) from the Department of Veterans Affairs (VA) for the procurement of a specific ophthalmic solution, Dorzolamide HCL 2% Ophthalmic Solution, packaged in 10 mL bottles. The RFQ is identified as 36C77025Q0023, with an estimated issue date of October 8, 2024, and a closing date set for October 16, 2024, at 09:00 AM CST. Key compliance requirements stem from the Drug Supply Chain Security Act (DSCSA), mandating that all suppliers verify their state wholesale distributor licensure with their bids, as non-compliance will render offers technically unacceptable. The document outlines required submissions, including a signed SF1449 cover page, a quote in an Excel format, compliance documentation, and a completed Trade Agreements Certificate. The estimated delivery for the ordered items is specified as November 4, 2024, allowing 10 days after receipt of order (ARO). Various VA CMOP locations across the U.S. are designated as shipping addresses for deliveries. This RFQ emphasizes safeguarding the integrity of the drug supply chain while fulfilling procurement needs for the VA.
    Similar Opportunities
    770-25-1-801-0134 -National CMOP ZINC OXIDE OINT
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Zinc Oxide Ointment as part of a contract with the National CMOP Office. Vendors are required to supply varying quantities of this pharmaceutical product, ensuring compliance with federal regulations, including the Drug Supply Chain Security Act and FDA approval. The ointment will be delivered to multiple VA CMOP facilities, with a total requirement exceeding 5,000 units, and must be shipped within 10 days of order receipt. Interested vendors must submit their proposals by December 30, 2024, at 4:00 PM Central Standard Time, including necessary documentation such as a signed SF1449 form and a Buy American Act certificate. For further inquiries, vendors can contact Sarah Fry at sarah.fry2@va.gov or call 913-758-9935.
    6505--Tamsulosin Capsules
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79725R0011 concerning the procurement of Tamsulosin Hydrochloride (HCL) Capsules. This procurement aims to ensure an uninterrupted supply of Tamsulosin HCL for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and other federal healthcare facilities, with one contract awarded to a responsible offeror capable of meeting these needs over a base period of one year, plus four optional one-year extensions. The estimated annual requirements include approximately 1.4 million bottles of 90-count Tamsulosin HCL 0.4mg capsules, along with options for larger packaging sizes, highlighting the importance of consistent medicinal supply for veteran healthcare. Interested vendors should note that the solicitation will be released electronically on or about January 7, 2025, with responses due by January 21, 2025; inquiries can be directed to Contract Specialist Andrew Cazares at Andrew.Cazares@va.gov or (708) 786-4990.
    6505--Verapamil Hydrochloride (HCL) Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting offers for the procurement of Verapamil Hydrochloride (HCL) Tablets, aimed at establishing a contract for the supply of this pharmaceutical product through the VA and Department of Defense Pharmaceutical Prime Vendor Programs. The solicitation requires compliance with current Good Manufacturing Practices (cGMP) and mandates a unique National Drug Code (NDC) for each product offered, ensuring adherence to FDA regulations and drug supply chain security measures. Interested contractors must submit their proposals by December 31, 2024, at 2:30 PM CST, and can direct inquiries to Contract Specialist Nicholas I. McGregor at Nicholas.McGregor@va.gov for further information.
    6505--Cyclobenzaprine Tablets (VA-25-00015093)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Cyclobenzaprine HCL Tablets under solicitation number 36E79725R0009. This unrestricted procurement aims to secure a reliable supply of these essential pharmaceuticals for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC), reflecting the government's commitment to providing necessary medications to veterans and associated healthcare systems. The contract will have an initial duration of one year, with the possibility of four additional one-year extensions, and interested vendors must provide specific drug labeling along with a unique National Drug Code (NDC). The RFP is expected to be released electronically around December 20, 2024, with a submission deadline set for January 3, 2025. For further inquiries, interested parties can contact Kenneth Lay at Kenneth.Lay@va.gov or by phone at 708-786-4879.
    6505--Carbidopa/Levodopa SA Tablet
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to issue a Request for Proposal (RFP) 36E79725R0008 for the procurement of Carbidopa/Levodopa sustained release (SA) tablets, aimed at ensuring a continuous supply of these medications for various federal health services, including the Department of Defense and the Bureau of Prisons. The contract will be awarded for an initial period of one year, with the option to extend for four additional one-year periods, requiring offerors to provide unique branding and packaging without overlapping labels. The estimated annual usage totals approximately 119,875 bottles across two dosage forms, highlighting the importance of these medications in treating Parkinson's disease and related conditions. Interested parties should note that the electronic solicitation is expected to be issued around January 3, 2026, with offers due by January 17, 2026; questions can be directed to the contracting officer, Chris Carthron, at Christopher.Carthron@va.gov.
    6509--Warfarin Tablets (VA-25-00012328)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking proposals for the supply of Warfarin NA tablets under solicitation number VA-25-00012328. The objective of this procurement is to establish a reliable supply contract for Warfarin tablets to ensure consistent availability and pricing through the VA and Department of Defense's Pharmaceutical Prime Vendor Programs. This initiative is crucial for maintaining a steady supply of essential pharmaceuticals, thereby supporting the government’s commitment to high-quality patient care and regulatory compliance. Interested offerors must submit their proposals by December 31, 2024, at 2:30 PM CST, and should direct any inquiries to Contracting Officer Adrienne A Albachiara at Adrienne.Albachiara@va.gov.
    6505--Abiraterone Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is soliciting proposals for the supply of Abiraterone Acetate Tablets through its Pharmaceutical Prime Vendor Program. Offerors are required to comply with the Drug Supply Chain Security Act (DSCSA) and Good Manufacturing Practices (cGMP), providing a unique 11-digit National Drug Code (NDC) for each drug, along with pricing for the base year and four optional years, including a Cost Recovery Fee. This procurement is crucial for ensuring consistent availability and competitive pricing of essential medications for federal healthcare users, particularly veterans. Interested parties must submit their proposals by the extended deadline of January 8, 2025, at 2:30 PM CST, and can contact Contract Specialist Richard Mahario at Richard.Mahario@va.gov for further information.
    6540--VISN 1 Optical IDIQ
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified contractors to provide prescription eyeglasses and optician services through an Indefinite Delivery Indefinite Quantity (IDIQ) contract for the VA New England Healthcare System. The contract, valued at an estimated $48 million, will span five years, requiring the contractor to deliver high-quality eyewear within five business days of order confirmation while adhering to strict quality assurance and compliance standards. This procurement is crucial for ensuring that veterans receive timely and accurate optical services, reflecting the government's commitment to high-quality care for its beneficiaries. Interested parties should contact Divianna N Mathurin at Divianna.Mathurin@va.gov for further details, with proposals due by the specified deadlines.
    760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.
    6505--Baclofen Tablets (VA-25-00026620)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) 36E79725R0015 for the procurement of Baclofen Tablets, aimed at ensuring a reliable supply for various federal health facilities, including the Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). The procurement will cover a one-year contract with four additional pre-priced option years, requiring offerors to provide products labeled with their unique National Drug Code (NDC) numbers. This initiative is critical for maintaining uninterrupted access to essential medications for veterans and other federal health service users. Interested suppliers should note that the solicitation will be electronically posted on or around December 30, 2024, with a submission deadline of January 13, 2025; inquiries can be directed to Contract Specialist Adrienne A. Albachiara at adrienne.albachiara@va.gov.